Skip to main content
rants_case-study-background-scaled-1

Our Grants

GRANT DATE AMOUNT PROGRAM
Aalborg University
Molecular Prediction of Crohn's Disease Using Network Analysis of Multi-Omics Data in Prediagnostic Samples
05.20.2025 $5,598,971.00 Crohn's Disease, Prevention
The University of Chicago
Characterization and longitudinal evaluation of subclinical perianal fistulizing Crohn's disease (pCD)
05.20.2025 $1,205,948.00 Crohn's Disease, Diagnostics
St. Mark's Hospital Foundation
Perianal Crohn's Disease (pCD) Educational Meeting and TOpCLASS Consortium Member Conference
02.18.2025 $164,712.00 Crohn's Disease, Diagnostics
Children's Hospital Medical Center
Validation of a Peripheral Blood Biomarker Signature for Anti-TNF Response in Patients with Crohn's Disease (ATPBioS)
02.03.2025 $1,876,476.00 Crohn's Disease, Diagnostics
Icahn School Of Medicine At Mount Sinai
The REFLECTION Study: Predicting Outcomes Following Ileocecal Resection in Crohn's Disease.
01.22.2025 $1,902,602.00 Crohn's Disease, Prevention
St. Mark's Hospital Foundation
Global Perianal Crohn's Disease Priority Setting Partnership
01.09.2025 $24,288.00 Crohn's Disease, Diagnostics
Crohn's & Colitis Foundation, Inc.
Achieving Remission in IBD: Optimizing Treat-to-Target in Clinical Practice
01.09.2025 $3,994,810.00 Crohn's Disease, Disease Management
Icahn School Of Medicine At Mount Sinai
Development of Novel LRRK2 Inhibitors to Treat Crohn's Disease
01.09.2025 $1,167,761.00 Crohn's Disease, Therapeutics
Icahn School Of Medicine At Mount Sinai
The Use of GLP-1R Agonists to Promote Epithelial Healing in Crohn's Disease
11.05.2024 $3,035,566.00 Crohn's Disease, Therapeutics
Alimentiv Inc.
Validation of the PRO Symptoms and Impacts Questionnaire for Crohn's Disease
11.05.2024 $1,275,257.00 Crohn's Disease, Diagnostics
Crohn's and Colitis UK
Implementation of a Lower GI Diagnostic Pathway in Primary Healthcare and development and dissemination of a Lower GI Patient Toolkit
11.05.2024 $638,508.00 Crohn's Disease, Disease Management
Mass General Brigham for the Brigham and Women's Hospital
Real-time Post-op Touchless, Remote Monitoring in Crohn's disease: The Sapphire Trial
10.22.2024 $5,117,928.00 Crohn's Disease, Disease Management
The Chancellor, Masters and Scholars of the University of Cambridge
New insights into Crohn's disease from studying Naked Mole Rats
10.22.2024 $1,857,860.00 Crohn's Disease, Disease Biology
Mass General Brigham for the Massachusetts General Hospital
Validation of Wireless Thermal and Microscopic Imaging Technology for Quantifying Inflammation and Fibrosis in Crohn's Disease
10.22.2024 $3,057,197.00 Crohn's Disease, Diagnostics
Crohn's & Colitis Foundation, Inc.
Sponsorship for the 2025 Crohn's & Colitis Congress presented by The Crohn's & Colitis Foundation and the American Gastroenterological Association
10.22.2024 $235,000.00 Crohn's Disease, Disease Management
Katholieke Universiteit te Leuven
Targeting chronic inflammation and tissue remodelling in Crohn's disease with engineered T cells
10.22.2024 $815,615.00 Crohn's Disease, Disease Biology
Board of Trustees of the Leland Stanford Junior University
Determining the Therapeutic Potential of Statins on Stricturing Crohn's Disease
10.09.2024 $2,034,990.00 Crohn's Disease, Therapeutics
The University of Edinburgh
Building a cross-discipline scientific approach towards understanding Crohn's disease - Leveraging UK Helmsley Studies
09.24.2024 $47,977.00 Crohn's Disease, Diagnostics
The Governors of the University of Calgary
A Drug-Wide Scan to Identify Repurposed Medications for Crohn's Disease
09.24.2024 $1,248,808.00 Crohn's Disease, Therapeutics
University of Glasgow Court
Title: Unraveling the role of the gut microbiome in postoperative outcomes and disease recurrence in surgical adults with Crohn's disease treated with exclusive enteral nutrition. The MI-OCEAN study
09.10.2024 $3,187,027.00 Crohn's Disease, Prevention
You can filter rows:
Prev 12...15 Next
1 - 20 of 293 results